Last CNY22.03 CNY
Change Today -0.16 / -0.72%
Volume 2.9M
002653 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for xizang haisco pharmaceutic-a (002653)

Year over year, Xizang Haisco Pharmaceutical Group Co., Ltd. has been able to grow revenues from CNY799.3M CNY to CNY986.7M CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 33.26% to 29.12%. This was a driver that led to a bottom line growth from CNY443.1M CNY to CNY519.2M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2010
Restated
CNY
Dec 31
2011
Restated
CNY
Dec 31
2012
Restated
CNY
Dec 31
2013
CNY
4 Year
Trend
Revenues581.6603.7799.3986.7
Other Revenues--0.82.85.7
TOTAL REVENUES581.6604.4802.1992.3
Cost of Goods Sold199.7200.9204.3268.7
GROSS PROFIT381.8403.5597.8723.6
Selling General & Admin Expenses, Total81.6112.9265.9287.3
Other Operating Expenses9.39.710.919.6
OTHER OPERATING EXPENSES, TOTAL90.9122.6276.8307.0
OPERATING INCOME290.9280.9321.0416.7
Interest Expense-1.6-0.1-0.7-3.4
Interest and Investment Income1.46.628.948.1
NET INTEREST EXPENSE-0.26.528.244.7
Currency Exchange Gains (Loss)--0.0-0.3-0.1
Other Non-Operating Income (Expenses)10.7-0.1----
EBT, EXCLUDING UNUSUAL ITEMS301.5287.4348.8461.3
Gain (Loss) on Sale of Assets-0.2-1.0-3.4-2.8
Other Unusual Items, Total62.683.1134.9110.4
Other Unusual Items62.683.1134.9110.4
EBT, INCLUDING UNUSUAL ITEMS363.9369.4480.3568.8
Income Tax Expense58.157.137.349.6
Earnings from Continuing Operations305.8312.3443.1519.2
NET INCOME305.8312.3443.1519.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS305.8312.3443.1519.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS305.8312.3443.1519.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002653:CH CNY22.03 CNY -0.16

002653 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002653.
View Industry Companies
 

Industry Analysis

002653

Industry Average

Valuation 002653 Industry Range
Price/Earnings 46.1x
Price/Sales 20.7x
Price/Book 11.4x
Price/Cash Flow 45.9x
TEV/Sales 20.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIZANG HAISCO PHARMACEUTIC-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.